Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 12, 2019

SELL
$83.92 - $108.88 $1.04 Million - $1.35 Million
-12,394 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$85.97 - $108.09 $104,883 - $131,869
1,220 Added 10.92%
12,394 $0
Q4 2018

Jan 16, 2019

BUY
$78.25 - $107.92 $98,516 - $135,871
1,259 Added 12.7%
11,174 $946,000
Q3 2018

Oct 11, 2018

BUY
$97.82 - $116.09 $67,202 - $79,753
687 Added 7.44%
9,915 $975,000
Q2 2018

Jul 11, 2018

BUY
$97.62 - $120.59 $120,560 - $148,928
1,235 Added 15.45%
9,228 $1.07 Million
Q1 2018

May 10, 2018

BUY
$95.91 - $107.26 $120,942 - $135,254
1,261 Added 18.73%
7,993 $789,000
Q4 2017

Jan 23, 2018

BUY
$104.5 - $126.38 $703,494 - $850,790
6,732
6,732 $705,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Hudson Capital Management LLC Portfolio

Follow Hudson Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Capital Management LLC with notifications on news.